Pharmacology I Drugs Used to Treat Arrhythmias. Arrhythmias Needing Treatment: Atrial Fibrillation/Flutter (AF) Supraventricular Tachycardia (SVT) Ventricular.

Slides:



Advertisements
Similar presentations
ACLS Medications.
Advertisements

Antiarrhythmic Agents: Cardiac Stimulants and Depressants
ARRHYTHMIAS TACHYCARDIA>100/min BRADYCARDIA
Or Doing Drugs for Your Heartbeat
Sinus Rhythms: Dysrhythmia Recognition & Management Terry White, RN, EMT-P.
Drugs for Dysrhythmias 19. Learning Outcomes 1. Explain how rhythm abnormalities can affect cardiac function. 2. Illustrate the flow of electrical impulses.
Cardiovascular Drugs.
Na+ channel blocker: Na+ channel block depends on: HR
October 6, 2006 Frank F. Vincenzi
Cardiac Arrhythmias.
Pharmacology in Nursing Antidysrhythmic Drugs
Drugs used to treat cardiac arrhythmias
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 45 Calcium Channel Blockers.
Calcium Channel Blocking Drugs.
Ventricular Arrhythmias Terry White, RN, EMT-P. Analyze the Rhythm.
Arrhythmias Medical Student Teaching Tuesday 24 th January 2012 Dr Karen Jones, SpR Emergency Medicine.
Arrhythmia Arrhythmias are abnormal beats of the heart.
Arrhythmia recognition and treatment
Anti-arrhythmic drugs
Anti arrhythmic Drugs Marwa A. Khairy , MD.
Clinical Use of Antiarrhythmic Agents
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 49 Antidysrhythmic Drugs.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
© Assoc. Prof. Ivan Lambev
Section 3, Lecture 4 Antiarrhytmic drugs cont…
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 23 Antiarrhythmic Drugs.
Antidysrhythmic Drugs
Supraventricular Arrhythmias Claire B. Hunter, M.D.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 23 Antidysrhythmic Drugs.
Chapter 17 Cardiac Stimulants and Depressants. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved
4-ANTIARRHYTHMIC DRUGS
Drugs for Arrhythmias.
Ventriclar Tachycardia
By Dr. Zahoor CARDIAC ARRHYTHMIA.
Antiarrhythmic Drugs Dr. Tom Murray Department of Pharmacology.
Cardiovascular Drugs That Prolong The QT Interval
Prof. Azza Hafiz El-Medany Prof. Abdulrahman Al-Motrefi.
23 Antiarrhythmic Drugs.
ANTI-ARRHYTHMIC DRUGS
Cardiovascular Medication
1 Case 9 Stable Tachycardias © 2001 American Heart Association.
Cardiac Stimulants and Depressants
Pharmacology 4 Dr. Khalil Makki. Antiarrhythmic Drugs.
Arrhythmia Arrhythmias are abnormal beats of the heart.
Prof. Abdulrahman Almotrefi
* QUINIDINE  Quinidine has pronounced cardiac anti muscarinic effects. It is absorbed orally. It undergoes extensive metabolism by the hepatic cytochrome.
Antiarrhythmic Drugs.
Dept. of Pharmacology Faculty of Medicine AIMST
ARRHYTHMIAS Jamil Mayet. Arrhythmias - learning objectives –Mechanisms of action of antiarrhythmic drugs –Diagnosis To differentiate the different types.
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 42 CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS.
Cardiovascular Cardiovascular pharmacology pharmacology.
Tachykardie / bradykardie
Result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood to meet the body's metabolic.
Drugs Used to Treat Dysrhythmias
Pharmacology Cardiovascular drugs Part I
CODE BLUE MANAGEMENT DRUG THERAPY
Calcium Channel Blocking Drugs.
Anti-arrhythmic drugs
Antidysrhythmic Agents
Drugs Affecting the Cardiovascular System
Treatment of Congestive Heart Failure
Ann Parker Cardiology Pharmacist Frimley Health
Review of Cardiovascular and Renal Drugs
Antiarrhythmic drugs [,æntiə'riðmik] 抗心律失常药
Drugs Acting on the Heart
Chapter 30 Antiarrhythmic Drugs
Antiarrhythmic Drugs Types of Cardiac Arrhythmias:
Arrhythmias Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium. However, in clinic it present as a complex family.
Drugs used in the treatment of arrhythmia I
Presentation transcript:

Pharmacology I Drugs Used to Treat Arrhythmias

Arrhythmias Needing Treatment: Atrial Fibrillation/Flutter (AF) Supraventricular Tachycardia (SVT) Ventricular Tachycardia (VT)

Drug Classifications: Ia Used For: Used to treat SVT, AF, VT Mechanism: Blocks Na+ Channels (slows action potential) ECG Effects: QRS and Q-T interval Examples: Quinidine (Quinora), Procainamide (Pronestyl), Disopyramide (Norpace)

Other Effects: Class Ia Slight increase in resting HR Causes peripheral vasodilation Which decreases TPR Which decreases BP Supresses PVC’s Quinidine Toxicity: Prolonged Q-T: Causes polymorphic VT –”Torsades de Pointe” Syncope

Exercise Capacity: Class Ia Drugs (ACSM Manual) No Change in Exercise Tolerance Exercise ECG: Prolonged Q-T intervals “False Positive” ST changes Exercise HR/BP unaffected

Drug Classification: Ib Used For: VT Mechanism: Blocks Na+ channels ECG Effects: Decreased Q-T Interval Examples: Lidocaine (Xylocaine), Tocainide (Tonocard), Phenytoin (Dilantin)

Other Effects: Class Ib Increases Preload Decreases Contractility (Reduces Ejection Fraction) Lidocaine Toxicity: May reduce CO and BP excessively Nevertheless: Well tolerated by CHF patients NO Significant Exercise Effects

Drug Classification: II Used For: SVT and AF Mechanism: Blocks Beta receptors for SNS and Adrenal stimulation ECG Effects: Prolong P-R interval and reduce HR Examples - Beta Adrenergic Blockers: Inderal, Lopressor, Corzide

Other Effects: ß-Blockers Reduce risk of prolonged Q-T intervals Reduces all types of tachycardias Adverse Effects: May disrupt glucose control and Hypoglycemic symptoms in Diabetics May exacerbate Cardiac failure in CHF Sudden Withdrawal is DANGEROUS

Exercise Effects: II Very Common Cardiac Drugs Exercise Tolerance: Improved in patients with angina Decreased in non-anginal patients Exercise ECG: HR and ischemic changes Hemodynamics: HR and BP at rest and Exercise

Drug Classification: III Used For: SVT, VT and AF Mechanisms: Na+/K+ channel blocker and many others ECG Effect: Prolong Q-T Examples: NAPA, Amiodarone

Other EffectsIII Other Effects: III Slows HR Decreases TPR (BP too) Increases Coronary Artery blood flow Slightly reduces contractility ADVERSE: symptomatic sinus brady, AV blocks, sinus arrest

Exercise Effects: III Exercise Tolerance: No change Exercise ECG: Decreased HR Hemodynamics: Decreased HR

And Finally: Class IV

Drug Classification: IV Used For: SVT and AF Mechanisms: Ca++ Channel Blockers ECG Effects: Decrease HR and Increase PR- Interval Examples: Verapamil (Calan), Diltiazem (Cardizem)

Other Effects: Class IV Used more for other cardiac effects – especially hypertension and ischemia Uncontrolled AF: Reduces Ventricular rate in AF (>100) Adverse Effects: Hypotension, bradycardia and rarely, ventricular asystole

Exercise Effects: IV Exercise Tolerance: Improved in patients with angina Exercise ECG: Reduced HR and ischemic ST changes Hemodynamics: Reduced blood pressure

What About Digitalis?

Cardiac Glycosides: Nightshade plant… Used For: SVT and AF Mechanisms: Inhibits Na+/K+- ATPase activity (maintains resting potential…) ECG Effects: QRS and Q-T Examples: Lanoxin

Other Effects: Digitalis Most commonly used to treat CHF Great Risk of Toxicity: Serum levels monitored closely Tachyarrhythmias Anorexia “Halo Vision” when looking at lights

Exercise And Digitalis: Exercise Tolerance: Improved in patients with CHF or AF ECG Effects: “Scooping” ST segment Hemodynamics: Some decrease in patients with AF /CHF